ARK Genomic Revolution ETF Equity-NMS: ARKG

$21.54 -0.7 (March 31, 2025)

-

-

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$22.24
Open :$22.15
Today's high :$22.2
Today's low :$21.37
52W low :$21.37
52W high :$31.16
1Y :-19.16%
5Y :-26.4%

Compare with Other ETFs

Frequently Asked Questions

What is ARK Genomic Revolution ETF (ARKG) price today?

The ARK Genomic Revolution ETF (ARKG) share price as of March 26, 2025 is $22.25. If you are investing from India, you can check the value in INR before investing.

Can I buy ARK Genomic Revolution ETF (ARKG) shares?

Yes, Indian investors can buy ARK Genomic Revolution ETF (ARKG) in the US stock market by opening an International Trading Account with Angel One.

How to buy ARK Genomic Revolution ETF (ARKG) Shares in India?

Indian investors can buy ARK Genomic Revolution ETF (ARKG) through the following modes:
  1. Direct investment: One can invest through opening an International Trading Account with Angel One. Once account is opened, you can add funds in U.S. dollars to buy ARK Genomic Revolution ETF (ARKG).
  2. Indirect investment: One can invest indirectly in ARK Genomic Revolution ETF (ARKG) through mutual funds and Exchange Traded Funds (ETFs) that offer exposure to global stocks.

Can I buy Fractional shares of ARK Genomic Revolution ETF (ARKG)?

Yes, you can buy a fraction of ARK Genomic Revolution ETF (ARKG). In Angel One, you can buy global stocks for any dollar value.

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.